Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ceranib-2 | CTRPv2 | pan-cancer | AAC | 0.0091 | 0.8 |
mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.8 |
mRNA | BRD-K85133207 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | NPC-26 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | 0.0093 | 0.8 |
mRNA | ML239 | CTRPv2 | pan-cancer | AAC | -0.0095 | 0.8 |
mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | 0.021 | 0.8 |